Uploaded April 2022 | Updated September 2026, 3 weeks ago
From innovations in automation and artificial intelligence that drive chemical and biological drug discovery to targeted delivery of novel therapies, SRI International is leading the way in the field of biosciences.
SRI Biosciences tackles some of the most challenging problems in medicine. For over 75 years, SRI research has driven the creation of novel technology platforms that generate first-in-class solutions to unmet drug discovery and medical needs.
We created SynFini™, a synthetic chemistry platform that leverages AI and automation so chemists can reduce development cycles and spend more time focusing on innovation.
Combining known medicinal chemistry procedures and machine learning, this multi-step, continuous suite of tools has demonstrated ability to dramatically streamline the chemical drug discovery and development process from years to months.
Another SRI platform is the FOX Three Molecular Guidance System, which dramatically expands the potential for intracellular drug delivery. This platform has overcome the challenge of delivering large biotherapeutic molecules into targeted cells.
Utilizing a proprietary technology, FOX Three can reach intracellular targets
that were essentially undruggable in the past. This platform has the potential to generate treatment breakthroughs for a range of diseases using a wide variety of “cargos”.
In addition to developing novel drug discovery and development platforms, SRI Biosciences performs collaborative research and provides pre-clinical services that take therapeutic candidates from discovery to the clinic.
SRI has numerous partnership models,enabling flexibility in its research and development
collaborations with industry and academic partners.
SRI Biosciences is the largest provider of preclinical services to the National Institutes of Health, and has successfully advanced over 150 drugs into the clinic.
SRI Biosciences’ research and development has changed the world of medicine.
We’re proud to continue our legacy of inventing and advancing products and technologies that improve lives.
__
At SRI, we’re inventing a better future together.
Connect with SRI:
http://www.linkedin.com/company/sri-i...
facebook.com/sri.intl
twitter.com/SRI_Intl
Subscribe to SRI’s newsletter at: sri.com
From innovations in automation and artificial intelligence that drive chemical and biological drug discovery to targeted delivery of novel therapies, SRI International is leading the way in the field of biosciences.
SRI Biosciences tackles some of the most challenging problems in medicine. For over 75 years, SRI research has driven the creation of novel technology platforms that generate first-in-class solutions to unmet drug discovery and medical needs.
We created SynFini™, a synthetic chemistry platform that leverages AI and automation so chemists can reduce development cycles and spend more time focusing on innovation.
Combining known medicinal chemistry procedures and machine learning, this multi-step, continuous suite of tools has demonstrated ability to dramatically streamline the chemical drug discovery and development process from years to months.
Another SRI platform is the FOX Three Molecular Guidance System, which dramatically expands the potential for intracellular drug delivery. This platform has overcome the challenge of delivering large biotherapeutic molecules into targeted cells.
Utilizing a proprietary technology, FOX Three can reach intracellular targets
that were essentially undruggable in the past. This platform has the potential to generate treatment breakthroughs for a range of diseases using a wide variety of “cargos”.
In addition to developing novel drug discovery and development platforms, SRI Biosciences performs collaborative research and provides pre-clinical services that take therapeutic candidates from discovery to the clinic.
SRI has numerous partnership models,enabling flexibility in its research and development
collaborations with industry and academic partners.
SRI Biosciences is the largest provider of preclinical services to the National Institutes of Health, and has successfully advanced over 150 drugs into the clinic.
SRI Biosciences’ research and development has changed the world of medicine.
We’re proud to continue our legacy of inventing and advancing products and technologies that improve lives.
__
At SRI, we’re inventing a better future together.
Connect with SRI:
http://www.linkedin.com/company/sri-i...
facebook.com/sri.intl
twitter.com/SRI_Intl
Subscribe to SRI’s newsletter at: sri.com
